Skip Content
You are currently on the new version of our website. Access the old version .

5 Results Found

  • Article
  • Open Access
1 Citations
1,543 Views
10 Pages

27 January 2025

Mesophilic microbial sources of prokaryotic Argonaute (pAgo) programmable nucleases have garnered considerable attention for their potential applications in genome editing and molecular diagnostics. In this study, we characterized a novel pAgo from t...

  • Article
  • Open Access
9 Citations
3,643 Views
14 Pages

21 September 2022

Argonaute proteins exist widely in eukaryotes and prokaryotes, and they are of great potential for molecular cloning, nucleic acid detection, DNA assembly, and gene editing. However, their overall properties are not satisfactory and hinder their broa...

  • Article
  • Open Access
416 Views
16 Pages

Targeting of Human Mitochondrial DNA with Programmable pAgo Nuclease

  • Beatrisa Rimskaya,
  • Ekaterina Kropocheva,
  • Elza Shchukina,
  • Egor Ulashchik,
  • Daria Gelfenbein,
  • Lidiya Lisitskaya,
  • Vadim Shmanai,
  • Svetlana Smirnikhina,
  • Andrey Kulbachinskiy and
  • Ilya Mazunin

10 January 2026

Manipulating the mitochondrial genome remains a significant challenge in genetic engineering, primarily due to the mitochondrial double-membrane structure. While recent advances have expanded the genetic toolkit for nuclear and cytoplasmic targets, p...

  • Article
  • Open Access
768 Views
13 Pages

16 October 2025

Argonaute (Ago) proteins are ubiquitous across all domains of life. Some prokaryotic Agos (pAgos) function as endonucleases that utilize short nucleic acid guides to recognize and cleave complementary targets. Yet, considerable diversity within pAgos...

  • Article
  • Open Access
11 Citations
3,001 Views
14 Pages

23 February 2022

Prokaryotic Argonautes (pAgos) from mesophilic bacteria are attracting increasing attention for their genome editing potential. So far, it has been reported that KmAgo from Kurthia massiliensis can utilize DNA and RNA guide of any sequence to effecti...